Clinical Trial Update: A Correlative Study of Biomarkers of Resistance in Patients With Castrate Resistant Prostate Cancer Treated With Abiraterone

View source ↗

Summary

This study update reports on biomarkers of resistance in castration-resistant prostate cancer patients treated with abiraterone, aiming to identify predictive m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abiraterone (abiraterone)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Prostate Cancer (Adenocarcinoma) | Status: COMPLETED